Author: Wolfgang Zink Bernhard M. Graf
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.27, Iss.14, 2004-01, pp. : 1093-1114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma
Drug Safety, Vol. 26, Iss. 7, 2003-01 ,pp. :
A Benefit-Risk Assessment of Sibutramine in the Management of Obesity
Drug Safety, Vol. 26, Iss. 14, 2003-01 ,pp. :
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
By Cahill Kate Stead Lindsay Lancaster Tim
Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. :